Smoking as a risk factor for dementia and cognitive decline: A meta-analysis of prospective studies

American Journal of Epidemiology

Volumn 166, Issue 4, 2007, Pages 367-378

  Anstey, Kaarin J ^a   Von Sanden, Chwee ^a   Salim, Agus ^a   O'Kearney, Richard ^b  

^a AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

^b AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Alzheimer disease; Cognition; Dementia, vascular; Meta analysis; Smoking

Indexed keywords

AGE STRUCTURE; COGNITION; COMPARATIVE STUDY; MEDICAL GEOGRAPHY; META-ANALYSIS; NERVOUS SYSTEM DISORDER; RISK FACTOR; SMOKING;

ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; DEMENTIA; FOLLOW UP; HUMAN; MINI MENTAL STATE EXAMINATION; MULTIINFARCT DEMENTIA; PROSPECTIVE STUDY; RISK FACTOR; SMOKING; SYSTEMATIC REVIEW;

AGED; COGNITION DISORDERS; DEMENTIA; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 34547679439     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwm116     Document Type: Article

References (56)

1. Elrod K, Buccafusco JJ, Jackson WJ. Nicotine enhances delayed matching-to-sample performance by primates. Life Sci 1988;43:277-87.
2. Salomon AR, Marcinowski KJ, Friedland RP, et al. Nicotine inhibits amyloid formation by the beta-peptide. Biochemistry 1996;35:13568-78.
3. Brayne C. Smoking and the brain. BMJ 2000;320:1087-8.
4. Almeida OP, Hulse GK, Lawrence D, et al. Smoking as a risk factor for Alzheimer's disease: contrasting evidence from a systematic review of case-control and cohort studies. Addiction 2002;97:15-28.
5. Dufouil C, Tzourio C, Brayne C, et al. Influence of apolipoprotein E genotype on the risk of cognitive deterioration in moderate drinkers and smokers. Epidemiology 2000;11:280-4.
6. Fontbonne A, Berr C, Ducimetiere P, et al. Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects: results of the Epidemiology of Vascular Aging Study. Diabetes Care 2001;24:366-70.
7. Luchsinger JA, Reitz C, Honig LS, et al. Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 2005;65:545-51.
8. Luchsinger JA, Tang MX, Shea S, et al. Antioxidant vitamin intake and risk of Alzheimer disease. Arch Neurol 2003;60:203-8.
9. Lindsay J, Laurin D, Verreault R, et al. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 2002;156:445-53.
10. Merchant C, Tang MX, Albert S, et al. The influence of smoking on the risk of Alzheimer's disease. Neurology 1999;52:1408-12.
11. Moffat SD, Zonderman AB, Metter EJ, et al. Free testosterone and risk for Alzheimer disease in older men. Neurology 2004;62:188-93.
12. Broe GA, Creasey H, Jorm AF, et al. Health habits and risk of cognitive impairment and dementia in old age: a prospective study on the effects of exercise, smoking and alcohol consumption. Aust N Z J Public Health 1998;22:621-3.
13. Juan D, Zhou DHD, Li J, et al. A 2-year follow-up study of cigarette smoking and risk of dementia. Eur J Neurol 2004;11:277-82.
14. Launer LJ, Andersen K, Dewey ME, et al. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. Neurology 1999;52:78-84.
15. Laurin D, Masaki KH, Foley DJ, et al. Midlife dietary intake of antioxidants and risk of late-life incident dementia: the Honolulu-Asia Aging Study. Am J Epidemiol 2004;159:959-67.
16. Wang HX, Fratiglioni L, Frisoni GB, et al. Smoking and the occurrence of Alzheimer's disease: cross-sectional and longitudinal data in a population-based study. Am J Epidemiol 1999;149:640-4.
17. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol 1992;135:1301-9.
18. de Craen AJ, Gussekloo J, Vrijsen B, et al. Meta-analysis of nonsteroidal antiinflammatory drug use and risk of dementia. Am J Epidemiol 2005;161:114-20.
19. Sutton A, Abrams K, Jones D, et al. Methods for meta-analysis in medical research. Chichester, United Kingdom: Wiley, 2000.
20. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
21. Higgins JP, Green S, eds. Cochrane handbook for systematic reviews of interventions 4.2.5 [updated May 2005]. In: The Cochrane Library, issue 3. Chichester, United Kingdom: John Wiley & Sons, Ltd, 2005.
22. Ford AB, Mefrouche Z, Friedland RP, et al. Smoking and cognitive impairment: a population-based study. J Am Geriatr Soc 1996;44:905-9.
23. Graves AB, Bowen JD, Rajaram L, et al. Impaired olfaction as a marker for cognitive decline: interaction with apolipoprotein E epsilon4 status. Neurology 1999;53:1480-7.
24. Launer LJ, Feskens EJ, Kalmijn S, et al. Smoking, drinking, and thinking. The Zutphen Elderly Study. Am J Epidemiol 1996;143:219-27.
25. Laurin D, Verreault R, Lindsay J, et al. Omega-3 fatty acids and risk of cognitive impairment and dementia. J Alzheimers Dis 2003;5:315-22.
26. Lui LY, Stone K, Cauley JA, et al. Bone loss predicts subsequent cognitive decline in older women: the study of osteoporotic fractures. J Am Geriatr Soc 2003;51:38-43.
27. Ott A, Andersen K, Dewey ME, et al. Effect of smoking on global cognitive function in nondemented elderly. Neurology 2004;62:920-4.
28. Paleologos M, Cumming RG, Lazarus R. Cohort study of vitamin C intake and cognitive impairment. Am J Epidemiol 1998;148:45-50.
29. Weisskopf MG, Wright RO, Schwartz J, et al. Cumulative lead exposure and prospective change in cognition among elderly men: the VA Normative Aging Study. Am J Epidemiol 2004;160:1184-93.
30. Whittington JE, Huppert FA. Smoking and cognitive decline. Hum Psychopharmacol 1997;12:467-80.
31. Yoshitake T, Kiyohara Y, Iwamoto H, et al. Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study. Neurology 1995;45:1161-8.
32. Bohannon AD, Fillenbaum GG, Pieper CF, et al. Relationship of race/ethnicity and blood pressure to change in cognitive function. J Am Geriatr Soc 2002;50:424-9.
33. Cervilla JA, Prince M, Mann A. Smoking, drinking, and incident cognitive impairment: a cohort community based study included in the Gospel Oak project. J Neurol Neurosurg Psychiatry 2000;68:622-6.
34. Chen WT, Wang PN, Wang SJ, et al. Smoking and cognitive performance in the community elderly: a longitudinal study. J Geriatr Psychiatry Neurol 2003;16:18-22.
35. Chi I, Chou KL. Depression predicts cognitive decline in Hong Kong Chinese older adults. Aging Ment Health 2000;4:148-57.
36. Herbert LE, Scherr PA, Beckett LA, et al. Relation of smoking and low-to-moderate alcohol consumption to change in cognitive function: a longitudinal study in a defined community of older persons. Am J Epidemiol 1993;137:881-91.
37. Knopman D, Boland LL, Mosley T, et al. Cardiovascular risk factors and cognitive decline in middle-aged adults. Neurology 2001;56:42-8.
38. Liang J, Borawski-Clark E, Liu X, et al. Transitions in cognitive status among the aged in Japan. Soc Sci Med 1996;43:325-37.
39. Piguet O, Grayson DA, Creasey H, et al. Vascular risk factors, cognition and dementia incidence over 6 years in the Sydney Older Persons Study. Neuroepidemiology 2003;22:165-71.
40. Richards M, Jarvis MJ, Thompson N, et al. Cigarette smoking and cognitive decline in midlife: evidence from a prospective birth cohort study. Am J Public Health 2003;93:994-8.
41. Sarti C, Pantoni L, Pracucci G, et al. Lipoprotein(a) and cognitive performances in an elderly white population: cross-sectional and follow-up data. Stroke 2001;32:1678-83.
42. Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung cancer risk. JAMA 2005;294:1505-10.
43. Serrano M, Madoz E, Ezpeleta I, et al. Smoking cessation and risk of myocardial reinfarction in coronary patients: a nested case-control study. (In Spanish). Rev Esp Cardiol 2003;56:445-51.
44. Castellsague X, Munoz N, De Stefani E, et al. Smoking and drinking cessation and risk of esophageal cancer (Spain). Cancer Causes Control 2000;11:813-18.
45. Bakhru A, Erlinger TP. Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey. PLoS Med 2005;2:e160.
46. Bruno RS, Traber MG. Vitamin E biokinetics, oxidative stress and cigarette smoking. Pathophysiology 2006;13:143-9.
47. Nilsson PM, Nilsson JA, Berglund G. Population-attributable risk of coronary heart disease risk factors during long-term follow-up: the Malmo Preventive Project. J Intern Med 2006;260:134-41.
48. Beeri MS, Rapp M, Silverman JM, et al. Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Neurology 2006;66:1399-404.
49. Ott A, Slooter AJ, Hofman A, et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet 1998;351:1840-3.
50. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44.
51. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-III-R. 3rd ed, rev. Washington, DC: American Psychiatric Association, 1987.
52. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-60.
53. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-24.
54. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 1994;57:416-18.
55. Zekry D, Hauw JJ, Gold G. Mixed dementia: epidemiology, diagnosis, and treatment. J Am Geriatr Soc 2002;50:1431-8.
56. Tyas SL, White LR, Petrovitch H, et al. Mid-life smoking and late-life dementia: the Honolulu-Asia Aging Study. Neurobiol Aging 2003;24:589-96.